ESG

KeHE's 2026 Summer Show gathered 5,000+ industry pros, unveiling key trends like regenerative organics and showcasing its role as a supply chain innovator.

Guerbet's Elucirem™ gains FDA approval for patients aged 0-2, halving gadolinium exposure in the most vulnerable without sacrificing diagnostic quality.

IPG's new data-driven Packaging Diagnostics program integrates remote monitoring and expert audits to boost uptime, cut costs, and improve sustainability.

A new study reveals adults with IDD are 9x more likely to have anxiety or depression, yet face immense barriers to care. This is a systemic failure.

Sōlaria Biō’s new study validates a microbe-based medical food, Bōndia™, offering a novel, science-backed approach to bone loss for millions of women.

New England Biolabs is launching next-gen sample prep tools, targeting long-read sequencing, RNA bias, and clinical epigenetics to accelerate discovery.

After eight years at the helm, the leader who steered the Baltic ferry giant through a pandemic and war announces his departure, sparking a search for a successor.

A new report reveals supporting family caregivers isn't just compassionate—it's a financially sound strategy for hospitals to cut costs and improve care.

The bakery giant announced its 94th straight quarterly dividend, but a weak 2026 forecast and high payout ratio raise questions about its sustainability.

Olenox Industries adds former Under Secretary of State Paula Dobriansky to its board, a move signaling a strategic push into complex global markets.

Safe Pro Group's AI-powered edge systems are heading to the U.S. Government, a key validation, yet market reaction raises questions about the deal's size.

New data reveals a targeted therapy can help patients with a rare, aggressive lung cancer even after their disease shows signs of worsening.

Singapore's Strutt Inc. sees unprecedented demand for its ev¹ Smart Everyday Vehicle. Now, the company faces the ultimate test: scaling up to deliver.

After a period of uncertainty, the digital asset firm has regained compliance with Nasdaq's bid price rule, a key step for its institutional ambitions.

F&G Annuities & Life declared its quarterly dividend, offering a sign of stability even as a recent earnings report and stock drop raise questions.

Cricket icon Rahul Dravid and Colgate Total are reframing oral care from simple hygiene to a critical performance ritual backed by compelling science.

As a historic cold snap gripped New York, renewable diesel kept essential city services running, proving its reliability in the most extreme conditions.

The chemical giant's dramatic dividend cut ends a 14-year growth streak, raising questions about sector health and long-term investor returns.

The miner posted a $2.9B free cash flow and a record $1.8B dividend payout, fueled by high gold prices and strategic growth in its 2025 earnings.

The junior explorer secures crucial funding from a renowned investor, fueling its nickel-copper ambitions in Canada's critical mineral heartland.